CA - Ro provides supply tracking feature for Lilly Novo Nordisk weight loss drugs May, 29 2024 12:11 PM CA Inc. 2024-05-29 12:11:20 ET More on Eli Lilly, Novo Nordisk Eli Lilly: Addressing Supply Challenges Should Accelerate Growth SA Asks: Is Eli Lilly or Novo Nordisk a better investment? Novo Nordisk: The Market Is Right, Don't Fight Against It SA Asks: Who will launch the next big weight-loss drug? Novo Nordisk: Considerable Growth Beyond Ozempic For further details see: Ro provides supply tracking feature for Lilly, Novo Nordisk weight loss drugs